These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8871612)

  • 61. Potential sites for processing of the human invariant chain by cathepsins D and E.
    Kageyama T; Yonezawa S; Ichinose M; Miki K; Moriyama A
    Biochem Biophys Res Commun; 1996 Jun; 223(3):549-53. PubMed ID: 8687433
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allele-dependent association of chicken MHC class I molecules with the invariant chain.
    Chen F; Pan L; Zhang J; Zhou X; Li J; Yu W
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):273-80. PubMed ID: 24948007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Major histocompatibility class II peptide occupancy, antigen presentation, and CD4+ T cell function in mice lacking the p41 isoform of invariant chain.
    Takaesu NT; Lower JA; Robertson EJ; Bikoff EK
    Immunity; 1995 Sep; 3(3):385-96. PubMed ID: 7553002
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E.
    Bennett K; Levine T; Ellis JS; Peanasky RJ; Samloff IM; Kay J; Chain BM
    Eur J Immunol; 1992 Jun; 22(6):1519-24. PubMed ID: 1601038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion.
    Hitzel C; Kanzler H; König A; Kummer MP; Brix K; Herzog V; Koch N
    FEBS Lett; 2000 Nov; 485(1):67-70. PubMed ID: 11086167
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Invariant chain retains MHC class II molecules in the endocytic pathway.
    Loss GE; Sant AJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3187-97. PubMed ID: 8468464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
    Maubach G; Lim MC; Kumar S; Zhuo L
    Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
    Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
    Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
    Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
    J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.
    Bangia N; Watts TH
    Int Immunol; 1995 Oct; 7(10):1585-91. PubMed ID: 8562503
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Both invariant chain isoforms Ii31 and Ii41 promote class II antigen presentation.
    Serwe M; Reuter G; Sponaas A; Koch S; Koch N
    Int Immunol; 1997 Jul; 9(7):983-91. PubMed ID: 9237107
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.
    Chiva C; Barthe P; Codina A; Gairí M; Molina F; Granier C; Pugnière M; Inui T; Nishio H; Nishiuchi Y; Kimura T; Sakakibara S; Albericio F; Giralt E
    J Am Chem Soc; 2003 Feb; 125(6):1508-17. PubMed ID: 12568610
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
    Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
    Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
    Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
    Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41.
    Sevilla LM; Comstock SS; Swier K; Miller J
    J Immunol; 2004 Aug; 173(4):2586-93. PubMed ID: 15294975
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing.
    Vergelli M; Pinet V; Vogt AB; Kalbus M; Malnati M; Riccio P; Long EO; Martin R
    Eur J Immunol; 1997 Apr; 27(4):941-51. PubMed ID: 9130648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The p41 fragment story.
    Turk D; Guncar G; Turk V
    IUBMB Life; 1999 Jul; 48(1):7-12. PubMed ID: 10791909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
    Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
    J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone.
    Manoury B; Mazzeo D; Li DN; Billson J; Loak K; Benaroch P; Watts C
    Immunity; 2003 Apr; 18(4):489-98. PubMed ID: 12705852
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proteases involved in MHC class II antigen presentation.
    Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
    Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.